Treatment of High-risk Venous Thrombosis Patients Using Low-dose Intraclot Injections of Recombinant Tissue Plasminogen Activator and Regional Anticoagulation-Reference-Cited by-同舟云学术

Treatment of High-risk Venous Thrombosis Patients Using Low-dose Intraclot Injections of Recombinant Tissue Plasminogen Activator and Regional Anticoagulation

Published:2013-01 Issue:1 Volume:24 Page:27-34.e1
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Chang Richard,Butman John A.,Lonser Russell R.,Sherry Richard M.,Pandalai Prakash K.,Horne McDonald K.,Lozier Jay N.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference14 articles.

1. Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal;Vedantham;J Vasc Interv Radiol,2006

2. Catheter-directed thrombolysis for acute limb ischemia;Morrison;Semin Intervent Radiol,2006

3. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy—American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (3rd edition);Horlocker;Reg Anesth Pain Med,2010

4. Low-dose, once-daily, intraclot injections of alteplase for treatment of acute deep venous thrombosis;Chang;J Vasc Interv Radiol,2011

5. Biochemical dynamics relevant to the safety of low dose, intraclot alteplase for deep vein thrombosis;Lozier;Transl Res,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose Tissue Plasminogen Activator is as Effective as Standard Tissue Plasminogen Activator Administration for the Treatment of Acute Ischemic Stroke;Current Neurovascular Research;2014-01-31